Fas-Lribozyme reduced significantly the number of infiltrating granulocytes in tumour nodules of 96 h and 18 days after cell inoculation (Figure 8B,D), but not the numbers of CD4+, CD8+ and NK cells. The gene discussed is CD8A; the disease is neoplasm.